December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Transduction of Primary Rabbit Lacrimal Acini With Replication-Incompetent Adenovirus Serotype 5 Inhibits Exocytosis and Transcytosis
Author Affiliations & Notes
  • SF Hamm-Alvarez
    Pharmaceutical Sciences
    University of Southern California Los Angeles CA
  • Y Wang
    Pharmaceutical Sciences
    University of Southern California Los Angeles CA
  • C Mazurek
    Institute for Genetic Medicine
    University of Southern California Los Angeles CA
  • N Kasahara
    Institute for Genetic Medicine
    University of Southern California Los Angeles CA
  • Footnotes
    Commercial Relationships   S.F. Hamm-Alvarez, None; Y. Wang, None; C. Mazurek, None; N. Kasahara, None. Grant Identification: NIH grants EY11386 and DK48522
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3139. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      SF Hamm-Alvarez, Y Wang, C Mazurek, N Kasahara; Transduction of Primary Rabbit Lacrimal Acini With Replication-Incompetent Adenovirus Serotype 5 Inhibits Exocytosis and Transcytosis . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3139.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To explore the effects of replication incompetent adenovirus serotype 5 (Ad) on lacrimal acinar secretory functions. Methods: Primary rabbit lacrimal acini cultured for two days were exposed to Ad containing either green fluorescent protein or ß-galactosidase reporter genes at a MOI of 5 for 24 hrs prior to measurement of basal and carbachol (CCH)-stimulated (100 µM) release of protein, ß-hexosaminidase, and secretory component (SC) derived from the polymeric immunoglobulin A receptor. Ad-induced changes in membrane and cytoskeletal organization were assessed by confocal microscopy using appropriate primary and secondary fluorophore-conjugated antibodies or fluorescent probes. Results: Transduction of lacrimal acini with Ad containing either reporter gene significantly (p <0.05) increased basal protein and ß-hexosaminidase release by 2-fold while concomitantly and significantly inhibiting the CCH-stimulated release of these same markers by 2-fold. While basal release of SC was not altered by Ad, the CCH-stimulated release of SC was significantly reduced by 2-fold. Ad transduction did not decrease cell viability or protein synthesis, as determined by trypan blue exclusion and pulse-labeling, respectively. No major changes in cytoskeletal filaments, Golgi membranes or immature VAMP2-enriched secretory vesicles could be detected by confocal microscopy. However, Ad transduction did elicit a major depletion of apical mature secretory vesicles enriched in rab3D. Conclusions: Replication-incompetent Ad markedly alters lacrimal acinar secretory responses, decreasing CCH-stimulated exocytosis and transcytosis while elevating basal exocytosis. The loss of apical rab3D-enriched secretory vesicles suggests that Ad may alter secretory vesicle maturation, thereby uncoupling stimulated and basal exocytosis. Ocular gene therapy strategies using Ad-derived materials may therefore alter the quantity and composition of tear fluid.

Keywords: 452 lacrimal gland • 307 adenovirus • 342 cell membrane/membrane specializations 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×